New Mexico
Register / Volume XXXV, Issue 11 / June 11, 2024
NOTICE OF REGULAR
BOARD MEETING AND RULE HEARING
The New Mexico Board of Pharmacy will convene on July 18th
and 19th, 2024 at 9:00 a.m. and continue until finished in the Board
of Pharmacy Conference Room located at 5500 San Antonio Dr., NE, Albuquerque,
NM 87109 for the purpose of conducting a regular board meeting and rule
hearing.
The agenda is posted 72 hours prior to the scheduled
meeting. You may view and download a
copy of the agenda through the board’s website: https://www.rld.nm.gov/boards-and-commissions/individual-boards-and-commissions/pharmacy/pharmacy-board-information/pharmacy-board-meetings/. All proposed language regarding rule hearings
is linked to the Agenda, the Notice to the Public on our website and
the New Mexico Sunshine Portal.
Individuals
petitioning the board regarding requests/waivers must submit documentation for
presentation; via fax (505) 222-9845, mail or email to the Board Administrator,
at the general e-mail pharmacy.board@rld.nm.gov at least one week in advance of
the scheduled meeting.
Interested
persons wishing to comment on proposed language regarding rule hearings may
submit documentation for presentation prior to the hearing; via fax (505)
222-9845, mail or email to the Board Administrator, at the general e-mail
pharmacy.board@rld.nm.gov in advance of the scheduled meeting. Public comment is also allowed during the
rule hearing.
If you are an individual with a
disability who is in need of a reader, amplifier,
qualified sign language interpreter, or any other form of auxiliary aid or
service, or if you are in need of a translator to attend or participate in the
hearing or meeting, please contact Board Administrator at 505-222-9830 at least
one week prior to the meeting or as soon as possible. Public documents, including the agenda and
minutes, can be provided in various accessible formats. Please contact Board Administrator at 505-222-9830
or e-mail pharmacy.board@rld.nm.gov if
a summary or other type of accessible format is needed.
Short explanation of the Purpose of Proposed Rule
Amendments: see below.
The full text of Proposed Rule Amendments for Rule Hearing
for July 18th, 2024, at 9:10 a.m. is available for each rule via the
Notice to the Public and agenda hyperlinks.
16.19.5 NMAC - INTERNSHIP TRAINING PROGRAM – Sections 1 and
5, administrative updates. Section 8,
updates, and removal of unnecessary or obsolete provisions. Remove suspension of preceptor certification
upon change of employment. Section 9 is
deleted (summary of objectives for last year pharmacy students in the rural
health care setting), as all provisions in that section are otherwise allowed
without additional requirements of previous Section 9.
STATUTORY AUTHORITY:
Paragraph (17) of Subsection A of Section 61-11-6 NMSA 1978 requires
that the Board of Pharmacy provide for the registration of pharmacist interns,
their certification, annual renewal of certification, training, supervision,
and discipline. Section 61-11-11 NMSA
1978 establishes qualifications for registration as a pharmacist intern. Pursuant to Subsection B of Section 61-11-12
NMSA 1978, the Board is authorized to issue an appropriate certificate of
registration or license to each person registered as a pharmacist intern.
16.19.30 NMAC - COMPOUNDING OF NON-STERILE PHARMACEUTICALS
– Section 6, administrative update. Section 7, add provision that addition of
flavoring agent subject to certain characteristics is not compounding. Section 9, update beyond use dating
specifications for consistency with updated United
States Pharmacopeia chapter for non-sterile compounding (“USP”). Section 10, change formulation records to
master formulation records, align requirements with USP, and align requirements
of compounding records with USP.
STATUTORY AUTHORITY:
Paragraph (6) of Subsection A of Section 61-11-6 NMSA 1978 requires that
the board of pharmacy provide for the licensing of retail pharmacies and
nonresident pharmacies and for the inspection of their facilities and
activities.
16.19.36 NMAC - COMPOUNDED STERILE PREPARATIONS – Section
7, remove, update, and add definitions for consistency with updated United
States Pharmacopeia chapters for sterile compounding (“USP”). Section 8, clarify that consultant pharmacist
for in-state clinics would be responsible for duties of the otherwise
pharmacist in charge. Section 9, 10, 11,
13 and 15, update for alignment with USP.
STATUTORY AUTHORITY:
Paragraph (6) of Subsection A of Section 61-11-6 NMSA 1978 authorizes
the board of pharmacy to provide for the licensing of all places where
dangerous drugs are stored, dispensed, distributed or administered and for the
inspection of their facilities and activities.
Paragraph (7) of Subsection A of 61-11-6 NMSA 1978 authorizes the board
to enforce the provisions of all laws of the state pertaining to the practice
of pharmacy and the manufacture, production, sale or distribution of drugs and
their standards of strength and purity.
Disciplinary Hearing(s): No
disciplinary hearings are currently scheduled.
If scheduling occurs, the final hearing date and time for each case will
be included in the agenda posted to the board’s website at least 72 hours
before the meeting.
Executive Director’s Report:
Published in NM Register:
June 11, 2024
Published in Albuquerque Journal: June 11, 2024